Acthera Therapeutics AG
PrivateLast Round
Grant
Jun 23, 2022
Total Funding Raised
$6.01M
Company Overview
Acthera Therapeutics AG is a biotechnology company that develops mechanosensitive hard-shelled liposomes for the targeted and controlled delivery of therapeutic payloads to treat acute cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acthera Therapeutics AG Comparables
Compare Acthera Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermosome GmbH | 71% | |
| LIPOSOMA B.V. | 66% | |
| TargED Biopharmaceuticals | 57% | |
Acthera Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2022 | ||||
| Seed | Jul 2, 2021 |
Acthera Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Seed |
| W.A. de Vigier Foundation | Grant |
| BERNINA BioInvest AG | Seed |
Acthera Therapeutics AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acthera Therapeutics AG's valuation, stock price, and market status.